As stated in the company’s announcement to the Athens Stock Exchange, a total amount of €3,048,000 was raised through the Share Capital Increase (hereinafter “SCI”), which was implemented pursuant to the Board of Directors’ decision dated 18.12.2020, following the resolution of the Extraordinary General Meeting of Shareholders dated 29.11.2019. The net proceeds, after deducting issuance expenses of €110,000, amounted to the aforementioned total.
The funds were fully allocated in accordance with the intended use set out in the Prospectus, which was approved by the Board of Directors of the Hellenic Capital Market Commission on 27.05.2021. This also includes subsequent decisions of the Company’s Board of Directors dated 17.06.2022, 24.03.2023, 06.08.2024, and 20.11.2024, which unanimously approved partial changes to the allocation of funds and revisions to the investment implementation timeline. These changes were duly ratified and approved, as required under Article 22, paragraph 3 of Law 4706/2020, by the General Meetings of the Company’s shareholders held on 09.09.2022, 22.09.2023, 13.09.2024, and 28.02.2025 respectively.
